Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy / Boriani, G.; Mei, D. A.; Imberti, J. F.. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 25:7(2023), pp. 978-980. [10.1002/ejhf.2891]

Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy

Boriani G.;Mei D. A.;Imberti J. F.
2023

2023
25
7
978
980
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy / Boriani, G.; Mei, D. A.; Imberti, J. F.. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 25:7(2023), pp. 978-980. [10.1002/ejhf.2891]
Boriani, G.; Mei, D. A.; Imberti, J. F.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1322378
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact